Trade
Alembic share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹121.00(3.37%)July 14, 2025 13:08:58 PM IST
- NSE
- BSE
- Vol : 814.27K (NSE + BSE)Last 20 day avg : 826.87 K
Alembic is trading 3.37% upper at Rs 121.00 as compared to its last closing price. Alembic has given -10.98% in this year & -1.16% in the last 5 days. Alembic has TTM P/E ratio 8.14 as compared to the sector P/E of 26.61.The company posted a net profit of 68.46 Crores in its last quarter.Listed peers of Alembic include Gufic Biosciences (-0.37%), Indoco Remedies (2.32%), Alembic (3.37%).The Mutual Fund holding in Alembic was at 3.36% in 30 Sep 2023. The MF holding has decreased from the last quarter. The FII holding in Alembic was at 1.65% in 31 Mar 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Key Metrics
Updated on Jul 15, 2025, 07:52 AM UTC
- Dividend YieldHigher than industry2.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values1.32The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values9.90Price-to-earnings ratio based on trailing 12-month earnings
- BetaMedium volatility1.11Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Alembic News
Alembic Financials
Financials
View allFinancials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
- Income
- Balance Sheet
- Cash Flow
Loading...
Units in the chart are in crores
Insights
- Financial
- Valuation
Company is profitable- The company's revenue grew in March quarter by 22.88% from Rs 60.27 crore to Rs 49.05 crore, year-on-year
The company's profit declined by 5.12% year-on-year during the March quarter, dropping from Rs 72.15 crore to Rs 68.46 crore- The debt to equity of the company is lower than the industry median
- Company can comfortably pay off its interest obligations with its earnings
Alembic Technical Analysis
Pivot Level - classic
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
- R1
- 126.45
- R2
- 131.10
- R3
- 136.50
Pivot121.05
- S1
- 116.40
- S2
- 111.00
- S3
- 106.35
Short Term
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Considers price movement over the last 6 months
Not Available
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Trends unavailable at the moment.
Alembic Peers
Return Comparison
Peers Comparison
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Gufic Biosciences | Moderately Bearish | 352.00 | -0.37 | 3,490.21 | 50.20 | 5.82 | 0.03 | 24.97 |
| Indoco Remedies | Bullish | 326.70 | 2.32 | 3,006.09 | - | 3.06 | 0.44 | 53.09 |
| Alembic | Bullish | 121.00 | 3.37 | 3,107.07 | 9.87 | 1.31 | 2.01 | 0.46 |
| Solara Active Pharma Sciences | Bullish | 668.95 | -0.65 | 3,226.34 | 4547.50 | 2.8 | - | 12.03 |
| Gujarat Themis Biosyn | Bullish | 360.70 | 0.14 | 3,945.06 | 76.28 | 14.99 | - | 11.93 |
Alembic Shareholding
View AllShareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
Shareholding pattern for Alembic is currently unavailable
Please check back later.
Shareholding Insights
- Promoter(s) holds a high stake in the company at 70.88%
- FIIs are invested in this company
- FIIs holding has decreased by 0.13 percentage points from previous quarter
- Mutual Funds are not invested in this company.
Alembic Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-02-07 | Quarterly Results & Other |
| 2024-11-08 | Quarterly Results & Other |
| 2024-08-12 | Quarterly Results |
| 2024-05-13 | Audited Results & Final Dividend |
About the company Alembic
- IndustryBiotechnology & Drugs
- ISININE426A01027
- BSE Code506235
- NSE CodeALEMBICLTD
Alembic Limited is an India-based company engaged in the business of development, manufacturing, and marketing of pharmaceutical products. The Company's segments include the Active Pharmaceutical Ingredients Business and the Real Estate Business. The Active Pharmaceutical Ingredients Business is engaged in the manufacturing and marketing of fermentation and chemistry-based active pharmaceutical ingredients (API). The Real Estate Business is engaged in the construction of residential and commercial real estate projects and project management and marketing consultancy. The Company provides certain commercial properties on a lease basis to various tenants. The Company is also engaged in research and development activities in Vadodara. It is also engaged in power generation through co-generation.
Alembic Share Price FAQs
Alembic is trading at 121.00 as on Mon Jul 14 2025 07:38:58. This is 3.37% upper as compared to its previous closing price of 117.05.
The market capitalization of Alembic is 3107.07 Cr as on Mon Jul 14 2025 07:38:58.
The 52 wk high for Alembic is 169.00 whereas the 52 wk low is 85.55
Alembic can be analyzed on the following key metrics -
- TTM P/E: 8.14
- Sector P/E: 26.61
- Dividend Yield: 2.05%
- D/E ratio: 0.01
Alembic reported a net profit of 310.68 Cr in 2025.
The Mutual Fund Shareholding was 3.36% at the end of 30 Sep 2023.
Quick Links